In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine
This research was conducted to investigate if there is a relation between insulin resistance incidence and inhibition of interferon gamma production or not. Firstly, insulin resistance was induced by high fat diet (HFD) intake for 6 weeks. Secondly, berberine was used as protective/curative compound...
Gespeichert in:
Veröffentlicht in: | Evidence-based complementary and alternative medicine 2016-01, Vol.2016 (2016), p.1-7 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7 |
---|---|
container_issue | 2016 |
container_start_page | 1 |
container_title | Evidence-based complementary and alternative medicine |
container_volume | 2016 |
creator | Elshehawy, Ashraf Abdelhamed Sahyoun, Heba Abdelghany Ghareeb, Doaa A. Mahmoud, Mohammad Ahmad Elsayed, Mohammad Mohammad |
description | This research was conducted to investigate if there is a relation between insulin resistance incidence and inhibition of interferon gamma production or not. Firstly, insulin resistance was induced by high fat diet (HFD) intake for 6 weeks. Secondly, berberine was used as protective/curative compound for insulin resistance. Results revealed that feeding rats HFD for 6 weeks developed features of insulin resistance (IR) syndrome. These features presented in increased body weight, hyperglycemia, hyperinsulinemia, hypercholesterolemia (with increased LDL-cholesterol and decreased HDL-cholesterol), and hypertriglyceridemia. Level of antioxidant enzymes in HFD group was higher than in normal one. Also there was an increasing in level of proinflammatory cytokines as interleukin- (IL-) 6 and IL-12 in HFD group. Feeding rats HFD for 6 weeks also decreased level of interferon gamma (IFN-γ). The decreased level of IFN-γ has been shown to predict infection with infectious diseases especially viral infection. Treatment and protection with berberine 50 mg/kg/day for 2 weeks were found to be effective against the features of insulin resistance syndrome, improved levels of insulin resistance parameters, lipid profile, antioxidant enzymes, proinflammatory cytokines, and IFN-γ. |
doi_str_mv | 10.1155/2016/2039897 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5013203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A610316522</galeid><sourcerecordid>A610316522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-430d6b71a73b44f0494fd55d22f80d531ea0926a4ddc5a2a0b693327663b8dd63</originalsourceid><addsrcrecordid>eNqNks1rFDEYxgdRbK3ePEvAi1BX850ZD0Jbal0oKFLFW8hM3nRTZpM1mdni3T_cDLOu1VMvyUveXx7ej6eqnhP8hhAh3lJMZDlYUzfqQXVIFCcLTuv64T5W3w-qJznfYEwbpdTj6oAqySkT5LD6tQzom99GtAwDpAS9GXwMeeU3qIXhFiCUTB57H9AXyD4PJnSATLDzBwcpBnRh1muDPqdox276_m6KByjxdmavVpDMBsbBd-jcuZJB0aFTSC0kH-Bp9ciZPsOz3X1Uff1wfnX2cXH56WJ5dnK56HjDhwVn2MpWEaNYy7nD5dFZISylrsZWMAIGN1Qabm0nDDW4lQ1jpVfJ2tpayY6q97PuZmzXYDsIQzK93iS_NumnjsbrfzPBr_R13GqBCSsjLgKvdgIp_hghD3rtcwd9bwLEMWtSM0q5KKu4B0qJqpuaT-jL_9CbOKZQJlEoImVZsLxDXZsetA8ulhK7SVSfSIIZkYLSQr2eqS7FnBO4fXcE68kvevKL3vml4C_uTmQP_zFIAY5nYOWDNbf-nnJQGHDmL10KbARnvwGvRtH3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1816601669</pqid></control><display><type>article</type><title>In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Elshehawy, Ashraf Abdelhamed ; Sahyoun, Heba Abdelghany ; Ghareeb, Doaa A. ; Mahmoud, Mohammad Ahmad ; Elsayed, Mohammad Mohammad</creator><contributor>Razzaque, Mohammed S.</contributor><creatorcontrib>Elshehawy, Ashraf Abdelhamed ; Sahyoun, Heba Abdelghany ; Ghareeb, Doaa A. ; Mahmoud, Mohammad Ahmad ; Elsayed, Mohammad Mohammad ; Razzaque, Mohammed S.</creatorcontrib><description>This research was conducted to investigate if there is a relation between insulin resistance incidence and inhibition of interferon gamma production or not. Firstly, insulin resistance was induced by high fat diet (HFD) intake for 6 weeks. Secondly, berberine was used as protective/curative compound for insulin resistance. Results revealed that feeding rats HFD for 6 weeks developed features of insulin resistance (IR) syndrome. These features presented in increased body weight, hyperglycemia, hyperinsulinemia, hypercholesterolemia (with increased LDL-cholesterol and decreased HDL-cholesterol), and hypertriglyceridemia. Level of antioxidant enzymes in HFD group was higher than in normal one. Also there was an increasing in level of proinflammatory cytokines as interleukin- (IL-) 6 and IL-12 in HFD group. Feeding rats HFD for 6 weeks also decreased level of interferon gamma (IFN-γ). The decreased level of IFN-γ has been shown to predict infection with infectious diseases especially viral infection. Treatment and protection with berberine 50 mg/kg/day for 2 weeks were found to be effective against the features of insulin resistance syndrome, improved levels of insulin resistance parameters, lipid profile, antioxidant enzymes, proinflammatory cytokines, and IFN-γ.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2016/2039897</identifier><identifier>PMID: 27642351</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Biological response modifiers ; Blood cholesterol ; Body weight ; Enzymes ; Ethylenediaminetetraacetic acid ; Glucose ; Health aspects ; Herbal medicine ; Hypercholesterolemia ; Insulin resistance ; Interferon gamma ; Interleukins ; Kinases ; Low density lipoproteins ; Medical research ; Medicine, Experimental ; Type 2 diabetes ; Viral infections</subject><ispartof>Evidence-based complementary and alternative medicine, 2016-01, Vol.2016 (2016), p.1-7</ispartof><rights>Copyright © 2016 Mohammad Ahmad Mahmoud et al.</rights><rights>COPYRIGHT 2016 John Wiley & Sons, Inc.</rights><rights>Copyright © 2016 Mohammad Ahmad Mahmoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2016 Mohammad Ahmad Mahmoud et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-430d6b71a73b44f0494fd55d22f80d531ea0926a4ddc5a2a0b693327663b8dd63</citedby><cites>FETCH-LOGICAL-c494t-430d6b71a73b44f0494fd55d22f80d531ea0926a4ddc5a2a0b693327663b8dd63</cites><orcidid>0000-0002-7693-1894 ; 0000-0003-3327-4377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013203/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013203/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27915,27916,53782,53784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27642351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Razzaque, Mohammed S.</contributor><creatorcontrib>Elshehawy, Ashraf Abdelhamed</creatorcontrib><creatorcontrib>Sahyoun, Heba Abdelghany</creatorcontrib><creatorcontrib>Ghareeb, Doaa A.</creatorcontrib><creatorcontrib>Mahmoud, Mohammad Ahmad</creatorcontrib><creatorcontrib>Elsayed, Mohammad Mohammad</creatorcontrib><title>In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>This research was conducted to investigate if there is a relation between insulin resistance incidence and inhibition of interferon gamma production or not. Firstly, insulin resistance was induced by high fat diet (HFD) intake for 6 weeks. Secondly, berberine was used as protective/curative compound for insulin resistance. Results revealed that feeding rats HFD for 6 weeks developed features of insulin resistance (IR) syndrome. These features presented in increased body weight, hyperglycemia, hyperinsulinemia, hypercholesterolemia (with increased LDL-cholesterol and decreased HDL-cholesterol), and hypertriglyceridemia. Level of antioxidant enzymes in HFD group was higher than in normal one. Also there was an increasing in level of proinflammatory cytokines as interleukin- (IL-) 6 and IL-12 in HFD group. Feeding rats HFD for 6 weeks also decreased level of interferon gamma (IFN-γ). The decreased level of IFN-γ has been shown to predict infection with infectious diseases especially viral infection. Treatment and protection with berberine 50 mg/kg/day for 2 weeks were found to be effective against the features of insulin resistance syndrome, improved levels of insulin resistance parameters, lipid profile, antioxidant enzymes, proinflammatory cytokines, and IFN-γ.</description><subject>Biological response modifiers</subject><subject>Blood cholesterol</subject><subject>Body weight</subject><subject>Enzymes</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Glucose</subject><subject>Health aspects</subject><subject>Herbal medicine</subject><subject>Hypercholesterolemia</subject><subject>Insulin resistance</subject><subject>Interferon gamma</subject><subject>Interleukins</subject><subject>Kinases</subject><subject>Low density lipoproteins</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Type 2 diabetes</subject><subject>Viral infections</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNks1rFDEYxgdRbK3ePEvAi1BX850ZD0Jbal0oKFLFW8hM3nRTZpM1mdni3T_cDLOu1VMvyUveXx7ej6eqnhP8hhAh3lJMZDlYUzfqQXVIFCcLTuv64T5W3w-qJznfYEwbpdTj6oAqySkT5LD6tQzom99GtAwDpAS9GXwMeeU3qIXhFiCUTB57H9AXyD4PJnSATLDzBwcpBnRh1muDPqdox276_m6KByjxdmavVpDMBsbBd-jcuZJB0aFTSC0kH-Bp9ciZPsOz3X1Uff1wfnX2cXH56WJ5dnK56HjDhwVn2MpWEaNYy7nD5dFZISylrsZWMAIGN1Qabm0nDDW4lQ1jpVfJ2tpayY6q97PuZmzXYDsIQzK93iS_NumnjsbrfzPBr_R13GqBCSsjLgKvdgIp_hghD3rtcwd9bwLEMWtSM0q5KKu4B0qJqpuaT-jL_9CbOKZQJlEoImVZsLxDXZsetA8ulhK7SVSfSIIZkYLSQr2eqS7FnBO4fXcE68kvevKL3vml4C_uTmQP_zFIAY5nYOWDNbf-nnJQGHDmL10KbARnvwGvRtH3</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Elshehawy, Ashraf Abdelhamed</creator><creator>Sahyoun, Heba Abdelghany</creator><creator>Ghareeb, Doaa A.</creator><creator>Mahmoud, Mohammad Ahmad</creator><creator>Elsayed, Mohammad Mohammad</creator><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7693-1894</orcidid><orcidid>https://orcid.org/0000-0003-3327-4377</orcidid></search><sort><creationdate>20160101</creationdate><title>In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine</title><author>Elshehawy, Ashraf Abdelhamed ; Sahyoun, Heba Abdelghany ; Ghareeb, Doaa A. ; Mahmoud, Mohammad Ahmad ; Elsayed, Mohammad Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-430d6b71a73b44f0494fd55d22f80d531ea0926a4ddc5a2a0b693327663b8dd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biological response modifiers</topic><topic>Blood cholesterol</topic><topic>Body weight</topic><topic>Enzymes</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Glucose</topic><topic>Health aspects</topic><topic>Herbal medicine</topic><topic>Hypercholesterolemia</topic><topic>Insulin resistance</topic><topic>Interferon gamma</topic><topic>Interleukins</topic><topic>Kinases</topic><topic>Low density lipoproteins</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Type 2 diabetes</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elshehawy, Ashraf Abdelhamed</creatorcontrib><creatorcontrib>Sahyoun, Heba Abdelghany</creatorcontrib><creatorcontrib>Ghareeb, Doaa A.</creatorcontrib><creatorcontrib>Mahmoud, Mohammad Ahmad</creatorcontrib><creatorcontrib>Elsayed, Mohammad Mohammad</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elshehawy, Ashraf Abdelhamed</au><au>Sahyoun, Heba Abdelghany</au><au>Ghareeb, Doaa A.</au><au>Mahmoud, Mohammad Ahmad</au><au>Elsayed, Mohammad Mohammad</au><au>Razzaque, Mohammed S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2016</volume><issue>2016</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>This research was conducted to investigate if there is a relation between insulin resistance incidence and inhibition of interferon gamma production or not. Firstly, insulin resistance was induced by high fat diet (HFD) intake for 6 weeks. Secondly, berberine was used as protective/curative compound for insulin resistance. Results revealed that feeding rats HFD for 6 weeks developed features of insulin resistance (IR) syndrome. These features presented in increased body weight, hyperglycemia, hyperinsulinemia, hypercholesterolemia (with increased LDL-cholesterol and decreased HDL-cholesterol), and hypertriglyceridemia. Level of antioxidant enzymes in HFD group was higher than in normal one. Also there was an increasing in level of proinflammatory cytokines as interleukin- (IL-) 6 and IL-12 in HFD group. Feeding rats HFD for 6 weeks also decreased level of interferon gamma (IFN-γ). The decreased level of IFN-γ has been shown to predict infection with infectious diseases especially viral infection. Treatment and protection with berberine 50 mg/kg/day for 2 weeks were found to be effective against the features of insulin resistance syndrome, improved levels of insulin resistance parameters, lipid profile, antioxidant enzymes, proinflammatory cytokines, and IFN-γ.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>27642351</pmid><doi>10.1155/2016/2039897</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7693-1894</orcidid><orcidid>https://orcid.org/0000-0003-3327-4377</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1741-427X |
ispartof | Evidence-based complementary and alternative medicine, 2016-01, Vol.2016 (2016), p.1-7 |
issn | 1741-427X 1741-4288 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5013203 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; PubMed Central; Alma/SFX Local Collection |
subjects | Biological response modifiers Blood cholesterol Body weight Enzymes Ethylenediaminetetraacetic acid Glucose Health aspects Herbal medicine Hypercholesterolemia Insulin resistance Interferon gamma Interleukins Kinases Low density lipoproteins Medical research Medicine, Experimental Type 2 diabetes Viral infections |
title | In Vivo Interrelationship between Insulin Resistance and Interferon Gamma Production: Protective and Therapeutic Effect of Berberine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T04%3A03%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Interrelationship%20between%20Insulin%20Resistance%20and%20Interferon%20Gamma%20Production:%20Protective%20and%20Therapeutic%20Effect%20of%20Berberine&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Elshehawy,%20Ashraf%20Abdelhamed&rft.date=2016-01-01&rft.volume=2016&rft.issue=2016&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2016/2039897&rft_dat=%3Cgale_pubme%3EA610316522%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1816601669&rft_id=info:pmid/27642351&rft_galeid=A610316522&rfr_iscdi=true |